Class 2 Medicines Recall: GL Pharma GmbH, Oxylan 40mg prolonged-release tablets, EL (20)A/41
GL Pharma is recalling a specific batch of Oxylan 40mg prolonged-release tablets due to out of specification results for dissolution during routine stability testing.
MDR Number
MDR 158-08/20
Company Name
GL Pharma GmbH
Product description
Oxylan 40mg prolonged-release tablets, PL 21597/0064
| Batch Number | Expiry Date | Pack Size | First Distributed |
|---|---|---|---|
| 9F119A | 31/05/2024 | 56 | 02/06/2020 |
Active pharmaceutical ingredient: oxycodone hydrochloride
Advice for healthcare professionals
Stop supplying the above batch immediately. Quarantine all stock and return it to your supplier using your supplier’s approved process.
Further information
For medical information enquiries please contact pv@gl-pharma.at
For stock control enquiries please contact david.hammond@healthcarepharma.co.uk
Recipients of this Drug Alert should bring it to the attention of relevant contacts by copy of this letter.
NHS England and NHS Improvement Regional Offices are asked to forward this alert to community pharmacy contractors.
Download document